Compare CNXN & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNXN | NEOG |
|---|---|---|
| Founded | 1982 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 1998 | 1989 |
| Metric | CNXN | NEOG |
|---|---|---|
| Price | $58.16 | $10.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.67 |
| AVG Volume (30 Days) | 63.5K | ★ 4.5M |
| Earning Date | 02-04-2026 | 01-08-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $2,878,704,000.00 | $880,319,000.00 |
| Revenue This Year | $5.74 | N/A |
| Revenue Next Year | $4.56 | $2.00 |
| P/E Ratio | $17.87 | ★ N/A |
| Revenue Growth | ★ 3.19 | N/A |
| 52 Week Low | $54.97 | $3.87 |
| 52 Week High | $74.84 | $11.96 |
| Indicator | CNXN | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 78.33 |
| Support Level | $56.20 | $9.61 |
| Resistance Level | $58.44 | $10.44 |
| Average True Range (ATR) | 1.32 | 0.59 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 61.78 | 96.24 |
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.